International Differences in Drug Prices
- 1 April 2004
- journal article
- review article
- Published by Annual Reviews in Annual Review of Public Health
- Vol. 25 (1) , 475-495
- https://doi.org/10.1146/annurev.publhealth.25.101802.123042
Abstract
This paper addresses how and why drug prices differ across countries. Studies of international variation in drug prices reach varied conclusions owing to methodological and data disparities. Price differences do exist across countries, with the United States footing the highest bill, but the differences are not nearly as large as they appear at first glance. The higher prices in the United States are concentrated among a subset of brand-name drugs and among those without insurance covering drugs. Some U.S. health plans obtain price concessions from manufacturers similar to those obtained by national governments. Price concessions occur whenever purchasers are willing to let price be a consideration in decisions about access and utilization. In low-income countries the vast majority are unwilling to pay for effective drugs simply because they are unable to pay. Low-income nations need more price discrimination—and vastly lower prices—if they are ever to afford the world's most effective medicines.Keywords
This publication has 14 references indexed in Scilit:
- Whither Seniors’ Pharmacare: Lessons From (And For) CanadaHealth Affairs, 2003
- Dilemmas In Regulation Of The Market For PharmaceuticalsHealth Affairs, 2003
- Pharmaceuticals and the Developing WorldJournal of Economic Perspectives, 2002
- Prescription Drug Prices: Why Do Some Pay More Than Others Do?Health Affairs, 2001
- International comparisons of pharmaceutical prices: what do we know, and what does it mean?Journal of Health Economics, 2000
- Cross-national price differences for pharmaceuticals: how large, and why?Journal of Health Economics, 2000
- Chapter 12 Health insurance and the labor marketPublished by Elsevier ,2000
- International Price Comparisons for PharmaceuticalsPharmacoEconomics, 1998
- Pharmaceutical Policies in CanadaPharmacoEconomics, 1998
- The Effects of Co-Payments within Drug Reimbursement ProgramsCanadian Public Policy, 1991